Skip to main content
. 2020 Aug 4;95(5):e469–e479. doi: 10.1212/WNL.0000000000010019

Table 2.

Baseline values and change from baseline in outcome measures during the active treatment phase (ATP)

graphic file with name NEUROLOGY2019018481TT2.jpg